Blood Cancers | Tumor

Whitesnake Guitarist John Sykes Died of Cancer, Mike Peters Starting CAR-T

January 24th 2025, 4:00pm

Article

From the deaths of John Sykes and former Planned Parenthood President Cecile Richards to an update from Mike Peters, here’s this week’s cancer news.

Putting an Emphasis on Patient Collaboration in MPN Treatment

January 6th 2025, 2:00pm

Video

Dr. Richard “Rick" Winneker discussed advice that he would provide to patients faced with a myeloproliferative neoplasm diagnosis.

FDA Grants Fast Track Designation to NX-5948 for R/R WM

December 30th 2024, 2:00pm

Article

NX-5948 has received fast track designation for adults with relapsed or refractory Waldenström macroglobulinemia who received at least two prior lines of therapy.

Top 4 Stories From the 2024 ASH Annual Meeting

December 24th 2024, 4:00pm

Article

CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple myeloma and other blood cancers.

Ryoncil Receives FDA Approval for Children With GVHD

December 18th 2024, 10:45pm

Article

This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.

‘Golden Bachelor’ Reveals Cancer Diagnosis, Ryne Sandberg’s Cancer Has Returned and More

December 13th 2024, 4:00pm

Article

From Gerry Turner announcing he has cancer to the return of a Chicago Cubs legend’s disease, here’s what’s happening in the cancer space this week.

Heart Risk May Occur Less With Some BTK Inhibitors in B-Cell Blood Cancers

December 9th 2024, 11:00pm

Article

In patients with certain B-cell blood cancers, heart-related side effects may occur less after receiving second-generation BTK inhibitors.

Pregnancy-Associated Hematological Malignancies Linked With Complications

November 29th 2024, 4:00pm

Article

Researchers have found an increased frequency of severe maternal morbidity and obstetric complications among women who received a diagnosis of a hematological malignancy during pregnancy.

Identifying Cardiovascular Disease Risk in Cancer Survivors

October 22nd 2024, 9:00pm

Article

The risk of cardiovascular disease is elevated in cancer survivors, regardless of treatment, and is influenced by cancer type and treatment-related factors.

Education on MPN Symptoms, Treatments Leads to Greater Involvement in Care

October 3rd 2024, 7:00pm

Article

An expert explained the importance of education and involvement in care for patients with myeloproliferative neoplasms.